Vidofludimus hemicalcium

SI-6537

Vidofludimus hemicalcium, >98% (HPLC)

CAS No. : [1354012-90-0]

Synonyms : 4SC-101 hemicalcium; SC-12267 hemicalcium

IUPAC Name : 2-((3-Fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylic acid hemicalcium

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Vidofludimus hemicalcium combines potent DHODH inhibition with FXR modulation, providing dual activity across immune and metabolic pathways. As an orally active immunomodulator, it is used in models of autoimmune disease such as IBD, while its FXR‑targeting properties make it suitable for investigating fatty‑liver pathology.

References : Yanlin Zhu et al.: Front. Pharmacol., 11, 590, 2020; Andreas Muehler et al.: Mult. Scler. Relat. Disord., 43, 102129, 2020; Leo R. Fitzpatrick et al.: J. Pharmacol. Exp. Ther., 342(3), 850-60, 2012.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.